Award recognizes Anumana’s innovative AI-driven cardiovascular disease detection technology

Company to highlight how its ECG-AI™ algorithms enable earlier cardiovascular disease detection

Company’s ECG-AI algorithm enables earlier heart failure detection

Program provides access to real-world data to refine AI algorithms for earlier detection of complex heart conditions

Data from Anumana’s New Study Show AI Algorithm Has the Potential to Detect Pulmonary Hypertension Early Using ECG DataCAMBRIDGE, Mass, June 27, 2024 Anumana, a leading AI-driven health technology company…

Anumana and InfoBionic.Ai Announce Collaboration to Advance AI-powered Remote Cardiac Telemetry Technology for Early Detection of Cardiac Diseases CAMBRIDGE, Mass. – June 25, 2024 – Anumana, a leading AI-driven health…

Anumana Demonstrates Global Readiness with Receipt of ISO 13485 CertificationCAMBRIDGE, Mass. – May 21, 2024 – Anumana, a leading AI-driven health technology company and portfolio company of nference, announced today…

Anumana Appoints Harry S. Palmin as CFOCAMBRIDGE, Mass. – May 14, 2024 Anumana, a leading AI-driven health technology company and portfolio company of nference, today announced the appointment of Harry…

Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available

Anumana Appoints Maulik Nanavaty as CEOCAMBRIDGE, Mass. – October 19, 2023 – Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, today announced that Maulik Nanavaty…